The use of magnesium sulfate (MgSO4) reduces the risk for preterm delivery following fetal surgery. However, it is associated with maternal complications. This prospective study was designed to evaluate if a policy of tocolytic titration is associated with fewer maternal complications. STUDY DESIGN: Patients undergoing fetal repair of spina bifida between July of 2012 and February of 2018 at a single institution were included. A policy of using a rigid tocolytic regimen with MgSO4 for a minimum of 48 hours was changed to a flexible one in which the MgSO4 was titrated according to the frequency of the uterine contractions following fetal surgery. The frequencies of maternal pulmonary edema, hypoxemia, atelectasis and hypocalcemia, as well as a composite of these outcomes, were compared before and after the policy was changed. Patient carrying a fetus with other major structural or chromosomal anomalies, and those whose tocolytic information could not be retrieved from the electronic medical record, were excluded. Chi-Square, Fisher's Exact and Mann-Whitney U Tests were used for comparisons and logistic regression analysis was performed to determine the relationship of tocolytic regimens with the study outcomes while controlling for gestational age at surgery, maternal BMI and type of surgery (open vs. fetoscopic). RESULTS: A total of 74 cases of fetal spina bifida repair were included. The rigid tocolytic regimen was used in 24.3% (18/74) and the flexible regimen was used in 75.7% (56/74) of cases. The flexible tocolytic regimen was associated with a lower frequency of atelectasis (p¼0.02) and a lower composite score of maternal complications compared to the rigid regimen [25% (14/56) vs. 50% (9/18); p¼0.046], a shorter length of stay on the labor and delivery unit (p<0.001), a lower total dose (p<0.001) of, and shorter duration on, MgSO4 (p¼0.002), and a higher gestational age at delivery (p¼0.023; although the latter is probably more dependent on a higher proportion of fetoscopic surgery) (See table). The flexible regimen was protective against a composite of maternal complications specifically associated with tocolysis (OR: 0.28; 95% CI: 0.082-0.94) after controlling for confounding variables. CONCLUSION: A policy of tocolytic titration is associated with fewer maternal complications associated with the use of MgSO4 following fetal repair of spina bifida, without any reduction in gestational age at delivery or increase in postoperative preterm delivery.
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